Dr. Shahid Aboobaker Merchant – Interventional Cardiologist and Advanced Heart Failure Specialist in Mumbai

Dr. Shahid Aboobaker Merchant is a Senior Consultant in Interventional Cardiology at Fortis Hospital Mulund, Mumbai. Fortis Healthcare lists 38 years of professional experience and describes his expertise in complex coronary interventions, advanced heart failure, structural heart procedures and the management of cardiogenic shock. His clinical background includes more than 30 years in interventional cardiology and additional specialised experience in advanced heart failure care.

Dr. Merchant completed his MBBS, MD in Medicine and DM in Cardiology before undertaking advanced interventional cardiology training overseas. His professional profiles describe training at the University of Rouen in France and Harvard-affiliated medical institutions in the United States, including Massachusetts General Hospital. His qualifications and fellowships reflect postgraduate training in cardiovascular medicine and catheter-based cardiac procedures.

His clinical interests include complex high-risk indicated percutaneous coronary interventions, commonly referred to as CHIP procedures. These treatments involve catheter-based approaches to selected complex coronary artery blockages. Dr. Merchant also has experience in advanced interventional techniques, including drug-coated balloon treatment and bioresorbable scaffold technology. Procedural selection depends on coronary anatomy, heart function, symptoms and the patient's overall clinical risk.

Structural heart intervention is another documented area of his professional expertise. This includes transcatheter aortic valve implantation, also known as TAVI or TAVR, for selected patients with severe aortic valve stenosis. Unlike conventional open surgical valve replacement, TAVI uses a catheter-based approach to place a replacement valve. Eligibility depends on detailed imaging and multidisciplinary heart-team assessment.

Dr. Merchant also has a specialist interest in advanced heart failure and cardiogenic shock. Patients with severe heart failure may require careful medication optimisation, evaluation of underlying cardiac disease and assessment for advanced therapies. Cardiogenic shock is a life-threatening condition that requires emergency hospital-based treatment and, in selected cases, mechanical circulatory support.

In addition to clinical practice, Dr. Shahid Aboobaker Merchant is involved in medical education and professional cardiology organisations. Fortis reports that he serves as Program Director for a Post-Doctoral Fellowship in Advanced Heart and Lung Failure and is Founder and CEO of the Heart Failure Foundation of India. His professional affiliations include FESC and FSCAI recognition. Patients seeking interventional cardiology or advanced heart failure consultation in Mumbai can enquire at Fortis Hospital Mulund regarding his current appointment availability.

Complex High-Risk Coronary Intervention (CHIP)

Complex high-risk indicated percutaneous coronary intervention involves catheter-based treatment of difficult coronary artery blockages in selected patients with complex anatomy or increased procedural risk. Treatment may require advanced imaging and specialised interventional techniques. The decision depends on coronary disease severity, heart function, patient condition and consideration of available medical or surgical alternatives.

Coronary Angiography

Coronary angiography is a diagnostic procedure used to examine the arteries supplying blood to the heart. A catheter delivers contrast material while X-ray imaging identifies narrowed or blocked coronary vessels. The findings help cardiologists determine whether medical treatment, angioplasty or coronary bypass surgery may be appropriate.

Percutaneous Coronary Intervention (PCI)

Percutaneous coronary intervention is a minimally invasive catheter-based procedure used to treat selected narrowed or blocked coronary arteries. It commonly involves balloon dilation and may include stent implantation. PCI may be performed during certain heart attacks or for appropriately selected coronary disease. Treatment decisions depend on symptoms, artery anatomy and clinical urgency.

Coronary Angioplasty

Coronary angioplasty involves using a small balloon to widen a narrowed section of a coronary artery. It may improve blood flow in selected patients with coronary artery disease. Angioplasty is often combined with stent placement, although treatment choices vary depending on the lesion and the patient's overall medical condition.

Coronary Stent Implantation

Coronary stent implantation involves placing a small expandable support structure inside a treated coronary artery to help keep it open. Modern drug-eluting stents release medicine that reduces the risk of tissue growth within the stent. Patients require appropriate follow-up and antiplatelet medication based on their clinical circumstances.

Drug-Coated Balloon Angioplasty

Drug-coated balloon angioplasty uses a balloon carrying medication designed to reduce excessive tissue growth after treatment of a narrowed blood vessel. It may be considered for selected coronary lesions, including certain cases of in-stent restenosis. The decision depends on vessel characteristics, lesion anatomy and current clinical evidence.

Bioresorbable Scaffold Interventions

Bioresorbable vascular scaffolds are temporary devices designed to support a treated coronary artery and gradually dissolve over time. Their use has been limited by safety and performance concerns associated with some earlier technologies. Suitability depends on the specific device, current evidence, regulatory status and careful patient selection.

Transcatheter Aortic Valve Implantation (TAVI)

Transcatheter aortic valve implantation is a catheter-based treatment for selected patients with severe aortic valve stenosis. A replacement valve is delivered into position, commonly through a blood vessel in the groin. Eligibility requires assessment of symptoms, valve anatomy, cardiac imaging, procedural risks and recommendations from a multidisciplinary heart team.

Cardiac Imaging Assessment

Cardiac imaging helps evaluate heart structure, blood flow, coronary disease and ventricular function. Investigations may include echocardiography, CT imaging, cardiac MRI or specialised imaging performed during catheter-based procedures. The appropriate technique depends on the clinical question, suspected diagnosis and the patient's overall condition.

Advanced Heart Failure Management

Advanced heart failure occurs when severe symptoms or impaired cardiac function persist despite appropriate medical treatment. Evaluation includes identifying underlying causes, optimising medicines and assessing suitability for advanced therapies. Selected patients may require multidisciplinary consideration of mechanical circulatory support, transplantation assessment or other specialised interventions.

Cardiogenic Shock Management

Cardiogenic shock is a life-threatening condition in which the heart cannot pump enough blood to maintain adequate circulation and organ function. It may occur after a severe heart attack or with advanced cardiac disease. Emergency management can involve medicines, urgent coronary intervention, intensive monitoring and mechanical circulatory support when indicated.

Mechanical Circulatory Support Assessment

Mechanical circulatory support devices may temporarily or continuously assist circulation in selected patients with severe cardiac failure. Options vary depending on the underlying condition, urgency and anticipated duration of support. Assessment requires careful consideration of device-related risks, organ function, treatment goals and the availability of specialised cardiac teams.

Complex Coronary Artery Disease Management

Complex coronary artery disease may involve multiple narrowed arteries, extensive calcification, difficult lesions or impaired ventricular function. Treatment planning can involve medication, advanced catheter-based interventions or referral for coronary bypass surgery. Cardiologists consider coronary imaging, symptom burden, heart function and patient-specific risks when recommending treatment.

Structural Heart Disease Assessment

Structural heart disease includes abnormalities affecting heart valves, chambers or associated structures. Evaluation commonly involves echocardiography, advanced imaging and multidisciplinary discussion. Some patients may be suitable for catheter-based procedures, while others require conventional surgery or medical management. Treatment depends on the condition, anatomy and clinical risk.

Interventional Cardiology Consultation

Interventional cardiology focuses on diagnosing and treating selected cardiovascular conditions using catheter-based techniques. Consultation may include reviewing symptoms, previous cardiac tests, coronary anatomy and possible treatment approaches. Recommendations can involve medication, additional investigations, angioplasty or structural heart interventions depending on the patient's medical needs.

Heart and Lung Failure Evaluation

Advanced heart and lung failure evaluation considers severe cardiac or respiratory conditions that may require specialist multidisciplinary care. Assessment includes organ function, underlying disease, response to treatment and the suitability of advanced therapies. Patients may require referral to dedicated heart failure, pulmonary or transplant services depending on the findings.